Thirteen percent of Americans—about 38 million people—suffer from migraine, and every one of them has a different experience with the condition. Treatment has to be as individualized as they are.

Among pediatric patients with available data, 72.2% (13/18) reported consistent headache relief and 36% (9/25) reported consistent freedom from headache. The Food and Drug Administration (FDA) has ...

Early diagnosis of a migraine is crucial, as it is linked to an increased risk of brain stroke. If you ignore this pain for a prolonged period, it could lead to a life-threatening situation. Neurology ...

Migraine sufferers are no strangers to major headaches. The onset of a migraine can be painful, disorienting and sometimes even debilitating. During National Migraine and Headache Awareness Month, Fox ...

When you buy through links on our articles, Future and its syndication partners may earn a commission. A GLP-1 agonist, the same class of drugs as Ozempic, may treat migraine, a study finds. | Credit: ...

Prof Fayyaz Ahmed, who has written a new book, believes migraines will not be cured in his lifetime.

Neurologist Dr. Susan Lee answers common questions about new treatments for migraine and where the future of migraine research is headed. Standard treatments taken at the onset of a migraine episode ...

Emgality is a monthly subcutaneous injection used to prevent episodic and chronic migraine. Migraine is a condition that causes intense throbbing or pulsating on one side of the head. Migraine may ...

Prospective treatment options for the future A plethora of treatment options for migraine are available today, and advances continue to be made in providing safer, more effective options for patients ...

For those with migraine, it can be a disabling neurological condition that disrupts work, family life, and daily routines ...

Migraines are increasing in frequency and intensity among Americans: Could climate change be a reason? Although the number of Americans who have migraines has remained stable for the last 30 years, ...

Nerivio is a wireless remote electrical neuromodulation device that is self-applied to the upper arm. Among pediatric patients with available data, 72.2% (13/18) reported consistent headache relief ...